PARIS, France and SHENZHEN, China, Oct. 15, 2025 /PRNewswire/ -- La Poste signed a Memorandum of Understanding (MOU) with the global e-commerce marketplace Temu, through its parcel delivery arm Colissimo, to strengthen logistics collaboration and support local sellers in France.
The partnership aims to improve services for French consumers and sellers, make it easier for local businesses to sell abroad, and promote more efficient logistics flows.
Under the MOU, La Poste Colissimo and Temu will explore a wide range of initiatives, including:
- Reliable parcel delivery in France, with flexible options for home delivery, pickup points, lockers and post offices across the country;
- International fulfillment solutions enabling Temu sellers to reach global shoppers through Colissimo's international network;
- Warehousing and flow management through Colissimo's logistics platforms.
As part of its strategy for responsible growth, Colissimo will bring to the partnership its logistics expertise, industrial infrastructure, technical solutions, and innovation capabilities. This includes ongoing efforts to cut carbon emissions from deliveries through the use of electric vehicles, eco-designed packaging, and urban delivery hubs.
"As France's leading postal and logistics provider, we are thrilled to partner with Temu to deliver innovative, sustainable, and efficient solutions for sellers and consumers," said Sanae Murschel, Vice President of International Sales at Colissimo, La Poste Group. "This MOU empowers us to strengthen our collaboration with TEMU. By combining our delivery and logistics capabilities with TEMU's innovative digital solutions, we aim to provide more efficient, compliant, and convenient services to both sellers and consumers across the markets we serve."
Through this collaboration, Colissimo and Temu will also launch a Local-to-Local Domestic Delivery Service, designed to offer French sellers on its platform an end-to-end shipping solution.
Leveraging Colissimo's extensive distribution network, the service will provide flexible parcel collection, nationwide delivery to homes, pickup points and lockers, as well as simple return management. Diversified options such as next-day delivery, same-day delivery in Paris, and delivery to retail outlets will also be available.
Beyond domestic logistics, the partnership will make it easier for French sellers to grow internationally, offering them streamlined logistics support to connect with consumers in new markets. Small and medium-sized businesses (SMBs) in particular are expected to benefit from simpler cross-border processes and transparent tracking.
"By combining Temu's marketplace with La Poste's trusted network, we can make it easier for local sellers to expand their reach in France and beyond," said a Temu spokesperson.
Temu entered France in 2023 and opened the marketplace to local sellers in France and across Europe last year. Since then, it has been providing them with a cost-effective channel to reach new customers and grow their businesses. Looking ahead, the company expects local sellers and local fulfilment to account for up to 80% of its European sales.
The MOU lays the groundwork for further agreements and projects to be developed jointly, in line with the evolving needs of French consumers, sellers, and the broader e-commerce ecosystem.
About Temu
Temu is a global e-commerce platform connecting consumers with millions of manufacturers, brands, and business partners. Operating in over 90 markets worldwide, Temu is committed to providing affordable, high-quality products that enable customers to live better lives.
About La Poste Groupe
La Poste is a state-owned public limited company, a subsidiary of Caisse des Dépôts and the French State. La Poste Groupe is divided into four business units: Services-Mail-Parcels, Retail Customers and Digital Services, Geopost and La Banque Postale, which, with its subsidiary CNP Assurances, is the 12th largest banking and insurance company in the Euro area.
La Poste Groupe carries out four public service missions that shape its identity: universal postal service, regional development, banking accessibility, and press transport and delivery. Committed to its regional coverage, La Poste Groupe relies on its network of local, human and digital services, the largest in France. This network consists of 40,500 service points including more than 17,000 contact points (post offices, local postal agencies, retail pickup points) and more than 23,500 access points to postal services (Pickup retail relays and lockers, business centers). La Poste Groupe delivers 2.6 billion parcels a year worldwide and 5.6 billion letters, 6 days a week. In 2024, La Poste Groupe generated a turnover of €34.6 billion (44.6% outside France) and had a headcount of 227,000, in more than 60 countries over 5 continents, of which 166,000 in France. Through its strategic plan "La Poste 2030, committed for you", the company is setting the course for profitable and responsible growth in France and internationally based on a robust multi-activity model. As a mission-driven company since June 2021 and a leader in ecological transition and sustainable finance, La Poste Groupe aims to achieve "Zero Net Emissions" by 2040.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
La Poste and Temu Sign MOU through its Colissimo delivery arm
|
The National University Centre for Digestive Health heralds a new era of care through quicker cross-referrals to surgical specialties, strengthened community partnerships and patient-friendly treatment delivery
SINGAPORE, Jan. 16, 2026 /PRNewswire/ -- Digestive health is central to overall well-being, influencing nutrition, immunity, and quality of life. Yet common conditions, such as ulcers, liver disease, and colorectal disorders, often go undetected until they lead to serious complications. To address this, the National University Hospital (NUH) has officially opened the National University Centre for Digestive Health (NUCD), a facility dedicated to early detection, advanced treatment, and seamless patient care for digestive diseases.
Since its concept launch in 2024, NUCD has focused on consolidating NUH's digestive health services under one roof to provide greater convenience for patients. Its reach extends beyond NUH, serving as a referral hub for complex cases from other hospitals within the National University Health System, including Ng Teng Fong General Hospital and Alexandra Hospital, ensuring patients receive specialised care when needed.
With its official opening, the Centre is strengthening the entire care pathway by accelerating access from initial digestive consultation to surgical expertise in Upper Gastrointestinal, Hepatobiliary and Pancreatic, and Colorectal, so patients can see the right specialists on the same day. This streamlined approach reduces waiting times, minimises repeated visits, and enables faster treatment decisions for better outcomes.
Strengthening prevention: From community collaborations to clinical excellence
NUCD has contributed significantly to the clinical validation and implementation of the Fibrosis-4 (FIB-4) score and fibroscan to screen for liver fibrosis, or scarring of the liver, in high-risk patients with fatty liver and other chronic liver diseases[1]. Since September 2022, a chronic liver disease screening programme for high-risk individuals has been launched in partnership with National University Polyclinics and General Practitioners (GP) clinics. Through consultations and routine health assessments done at these clinics, asymptomatic individuals identified as potentially high-risk are referred to NUCD for comprehensive screening. To date, the Centre has screened more than 12,000 high-risk patients, facilitating earlier detection and interventions. With continuing medical education and engagement, NUCD continues to expand this network to enhance preventive care for liver health.
Another key focus of the Centre is improving the detection of colorectal cancer, often called a 'silent killer' because symptoms usually appear only in later stages. According to the Singapore Cancer Registry Annual Report 2022[2], colorectal cancer is the second most common cancer and the second leading cause of cancer-related deaths locally. To tackle this, the Centre is improving colonoscopy quality by increasing the Adenoma Detection Rate (ADR), a measure of how often doctors detect and remove precancerous polyps during the procedure.
Studies[3] show that every 1 per cent increase in ADR lowers colorectal cancer risk by 3 per cent, making these improvements a vital step in prevention. Put simply, a higher ADR means that more polyps are removed early, reducing cancer risk. New initiatives such as AI-enabled and image-enhanced colonoscopy, an automated ADR calculation system, and a dashboard displaying critical quality indicators for endoscopists have helped boost ADR at NUCD from 33.5 per cent in 2022 to 42.4 per cent in 2025, well above the American Society for Gastrointestinal Endoscopy guideline of at least 25 per cent[4].
Making IBD care more convenient and precise
Established in 2016, the Inflammatory Bowel Disease (IBD) Centre of Excellence is now a cornerstone of NUCD, delivering advanced care across all ages - from paediatric to adult patients. Among its key innovations is the home administration of intravenous biologics, reducing the need for frequent hospital visits and improving convenience.
Others include point-of-care intestinal ultrasound, which enables real-time, non-invasive assessment during clinic consultations, and a translational precision medicine programme that personalises treatment and provides access to clinical trials and novel therapies, such as faecal microbiota transplantation. The IBD Centre of Excellence also aims to play a leading role in regional education, having hosted IBD training programmes for over 100 healthcare professionals from ASEAN countries in the past five years.
"The launch of NUCD marks a significant step forward in how we care for patients with digestive conditions," said Adj A/Prof Lee Guan Huei, Centre Director, National University Centre for Digestive Health. "By bringing together advanced diagnostics, specialist expertise, and cutting-edge technology, we aim to deliver care that is faster, more precise, and patient-focused. At the same time, we are driving research into new detection methods and innovative therapies, such as blood-based diagnostic tools that reduce the need for invasive procedures while maintaining accuracy. Our goal is simple - to detect problems early, treat them well, and help our patients live healthier lives." Adj A/Prof Lee is also Head and Senior Consultant, Division of Gastroenterology and Hepatology, Department of Medicine, NUH.
About the National University Hospital (NUH)
The National University Hospital (NUH) is Singapore's leading university hospital. While the hospital at Kent Ridge first received its patients on 24 June 1985, our legacy started from 1905, the date of the founding of what is today the NUS Yong Loo Lin School of Medicine. NUH is the principal teaching hospital of the medical school.
Our unique identity as a university hospital is a key attraction for healthcare professionals who aspire to do more than practise tertiary medical care. We offer an environment where research and teaching are an integral part of medicine, and continue to shape medicine and transform care for the community we care for.
We are an academic medical centre with over 1,200 beds, serving more than one million patients a year with over 50 medical, surgical and dental specialties. NUH is the only public and not-for-profit hospital in Singapore to provide trusted care for adults, women and children under one roof, including the only paediatric kidney and liver transplant programme in the country.
The NUH is a key member of the National University Health System (NUHS), one of three public healthcare clusters in Singapore. For more information, visit www.nuh.com.sg
Follow us on
Facebook | Instagram | LinkedIn | TikTok | YouTube
| [1] Chew NWS, Ng CH, Chan KE, et al. FIB-4 Predicts MACE and Cardiovascular Mortality in Patients With Nonalcoholic Fatty Liver Disease. Can J Cardiol 2022 Nov;38(11):1779-1780. |
| [2] Singapore Cancer Registry Annual Report 2022, September 2024, https://www.nrdo.gov.sg/publications/cancer |
| [3] Corley DA, Levin TR, Doubeni CA.Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:2541. |
| [4] Song YM, Han KS, Kim BC, Hong CW, Kim B, Kim MC, Jin MJ, Sohn DK. Analysis of adenoma detection rate of colonoscopy among trainees. Ann Coloproctol. 2024 Dec;40(6):548-554. doi: 10.3393/ac.2023.00199.0028. Epub 2024 Aug 28. PMID: 39191316; PMCID: PMC11701454. |
The National University Centre for Digestive Health heralds a new era of care through quicker cross-referrals to surgical specialties, strengthened community partnerships and patient-friendly treatment delivery
SINGAPORE, Jan. 16, 2026 /PRNewswire/ -- Digestive health is central to overall well-being, influencing nutrition, immunity, and quality of life. Yet common conditions, such as ulcers, liver disease, and colorectal disorders, often go undetected until they lead to serious complications. To address this, the National University Hospital (NUH) has officially opened the National University Centre for Digestive Health (NUCD), a facility dedicated to early detection, advanced treatment, and seamless patient care for digestive diseases.
Since its concept launch in 2024, NUCD has focused on consolidating NUH's digestive health services under one roof to provide greater convenience for patients. Its reach extends beyond NUH, serving as a referral hub for complex cases from other hospitals within the National University Health System, including Ng Teng Fong General Hospital and Alexandra Hospital, ensuring patients receive specialised care when needed.
With its official opening, the Centre is strengthening the entire care pathway by accelerating access from initial digestive consultation to surgical expertise in Upper Gastrointestinal, Hepatobiliary and Pancreatic, and Colorectal, so patients can see the right specialists on the same day. This streamlined approach reduces waiting times, minimises repeated visits, and enables faster treatment decisions for better outcomes.
Strengthening prevention: From community collaborations to clinical excellence
NUCD has contributed significantly to the clinical validation and implementation of the Fibrosis-4 (FIB-4) score and fibroscan to screen for liver fibrosis, or scarring of the liver, in high-risk patients with fatty liver and other chronic liver diseases[1]. Since September 2022, a chronic liver disease screening programme for high-risk individuals has been launched in partnership with National University Polyclinics and General Practitioners (GP) clinics. Through consultations and routine health assessments done at these clinics, asymptomatic individuals identified as potentially high-risk are referred to NUCD for comprehensive screening. To date, the Centre has screened more than 12,000 high-risk patients, facilitating earlier detection and interventions. With continuing medical education and engagement, NUCD continues to expand this network to enhance preventive care for liver health.
Another key focus of the Centre is improving the detection of colorectal cancer, often called a 'silent killer' because symptoms usually appear only in later stages. According to the Singapore Cancer Registry Annual Report 2022[2], colorectal cancer is the second most common cancer and the second leading cause of cancer-related deaths locally. To tackle this, the Centre is improving colonoscopy quality by increasing the Adenoma Detection Rate (ADR), a measure of how often doctors detect and remove precancerous polyps during the procedure.
Studies[3] show that every 1 per cent increase in ADR lowers colorectal cancer risk by 3 per cent, making these improvements a vital step in prevention. Put simply, a higher ADR means that more polyps are removed early, reducing cancer risk. New initiatives such as AI-enabled and image-enhanced colonoscopy, an automated ADR calculation system, and a dashboard displaying critical quality indicators for endoscopists have helped boost ADR at NUCD from 33.5 per cent in 2022 to 42.4 per cent in 2025, well above the American Society for Gastrointestinal Endoscopy guideline of at least 25 per cent[4].
Making IBD care more convenient and precise
Established in 2016, the Inflammatory Bowel Disease (IBD) Centre of Excellence is now a cornerstone of NUCD, delivering advanced care across all ages - from paediatric to adult patients. Among its key innovations is the home administration of intravenous biologics, reducing the need for frequent hospital visits and improving convenience.
Others include point-of-care intestinal ultrasound, which enables real-time, non-invasive assessment during clinic consultations, and a translational precision medicine programme that personalises treatment and provides access to clinical trials and novel therapies, such as faecal microbiota transplantation. The IBD Centre of Excellence also aims to play a leading role in regional education, having hosted IBD training programmes for over 100 healthcare professionals from ASEAN countries in the past five years.
"The launch of NUCD marks a significant step forward in how we care for patients with digestive conditions," said Adj A/Prof Lee Guan Huei, Centre Director, National University Centre for Digestive Health. "By bringing together advanced diagnostics, specialist expertise, and cutting-edge technology, we aim to deliver care that is faster, more precise, and patient-focused. At the same time, we are driving research into new detection methods and innovative therapies, such as blood-based diagnostic tools that reduce the need for invasive procedures while maintaining accuracy. Our goal is simple - to detect problems early, treat them well, and help our patients live healthier lives." Adj A/Prof Lee is also Head and Senior Consultant, Division of Gastroenterology and Hepatology, Department of Medicine, NUH.
About the National University Hospital (NUH)
The National University Hospital (NUH) is Singapore's leading university hospital. While the hospital at Kent Ridge first received its patients on 24 June 1985, our legacy started from 1905, the date of the founding of what is today the NUS Yong Loo Lin School of Medicine. NUH is the principal teaching hospital of the medical school.
Our unique identity as a university hospital is a key attraction for healthcare professionals who aspire to do more than practise tertiary medical care. We offer an environment where research and teaching are an integral part of medicine, and continue to shape medicine and transform care for the community we care for.
We are an academic medical centre with over 1,200 beds, serving more than one million patients a year with over 50 medical, surgical and dental specialties. NUH is the only public and not-for-profit hospital in Singapore to provide trusted care for adults, women and children under one roof, including the only paediatric kidney and liver transplant programme in the country.
The NUH is a key member of the National University Health System (NUHS), one of three public healthcare clusters in Singapore. For more information, visit www.nuh.com.sg
Follow us on
Facebook | Instagram | LinkedIn | TikTok | YouTube
[1] Chew NWS, Ng CH, Chan KE, et al. FIB-4 Predicts MACE and Cardiovascular Mortality in Patients With Nonalcoholic Fatty Liver Disease. Can J Cardiol 2022 Nov;38(11):1779-1780.
[2] Singapore Cancer Registry Annual Report 2022, September 2024, https://www.nrdo.gov.sg/publications/cancer
[3] Corley DA, Levin TR, Doubeni CA.Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:2541.
[4] Song YM, Han KS, Kim BC, Hong CW, Kim B, Kim MC, Jin MJ, Sohn DK. Analysis of adenoma detection rate of colonoscopy among trainees. Ann Coloproctol. 2024 Dec;40(6):548-554. doi: 10.3393/ac.2023.00199.0028. Epub 2024 Aug 28. PMID: 39191316; PMCID: PMC11701454.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
NUH INAUGURATES NEW CENTRE TO ADVANCE PREDICTIVE AND ACCESSIBLE CARE FOR DIGESTIVE HEALTH